In July 2019 the head of the Federal Antimonopoly Service Igor Artemiev at a meeting with Russian President Vladimir Putin said that in Russia, the problem of cartels is now most acute in the pharmaceutical industry. Three months later, we can see the progress in the battle with the cartels.
According to RIA news last week, The Federal Antimonopoly Service (FAS) of Russia fined the participants of the drug cartel Firm Euroservice and Mega Pharma 283.5 million rubles - "CJSC Firma Euroservice and LLC Mega Pharma will pay 234 million rubles and 49.5 million rubles, respectively. The amount of income of cartel members amounted to more than 800 million rubles. The court of appeal supported the decision of the antimonopoly body".
Earlier, the antimonopoly service admitted that these firms violated the law on the protection of competition by participating in 331 electronic auctions for the supply of medicines and medical devices to state hospitals. Mr Andrey Tenishev, the head of the FAS cartel control department commented on the issue: "Targeted anticompetitive behaviour of companies can be traced not only in their participation in a cartel conspiracy but also in giving bribes to employees of medical institutions. To discourage such illegal activities and the possibility of relapse, the antimonopoly body, imposes significant fines on violators and submits materials to law enforcement agencies to decide on criminal prosecution cases regarding unfair business".